Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1401 - 1417 of 1417 in total
Clorobiocin is an aminocoumarin antibiotic, similar to novobiocin and coumermycin A1.
Experimental
Investigational
Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of...
Investigational
Cronidipine is a calcium channel blocker.
Experimental
Neladenoson bialanate has been investigated for the treatment of Heart Failure.
Investigational
Canfosfamide is an active agent in chemotherapy-resistant ovarian cancer.
Investigational
Idasanutlin has been used in trials studying the treatment of Neoplasms, Non-Hodgkin's Lymphoma, Leukemia, Myeloid, Acute, Recurrent Plasma Cell Myeloma, and Neoplasms, Leukemia, Acute Myeloid Leukemia.
Investigational
Experimental
Acyline has been investigated for the prevention and treatment of Hypogonadism and Contraception.
Investigational
Ozarelix has been used in trials studying the treatment of Prostate Cancer, Benign Prostatic Hypertrophy, and Benign Prostatic Hyperplasia (BPH).
Investigational
Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Ramoplanin is a novel glycolipodepsipeptide antibiotic under development for the treatment of CDAD.
Investigational
Experimental
Displaying drugs 1401 - 1417 of 1417 in total